Aflac is projected to report Q3 2026 revenue of $4.12 billion and EPS of $1.80, with its current $123.89 stock price trading slightly above the $117.20 average analyst target.
Investors are primarily focused on the Aflac Japan benefit ratio, which management previously guided toward the high end of its 60% to 63% range for the 2026 fiscal year.
The company continues to navigate a projected 10.4% year-over-year decline in net investment income alongside persistent currency headwinds from the yen. To mitigate these pressures, Aflac recently completed $4.8 billion in portfolio switch trades designed to improve yield and support long-term capital deployment.